Acceptance and Attitude toward COVID-19 Vaccination among the Public in Saudi Arabia: A Cross-sectional Study
Eyad M Alduwayghiri, Nubesh Khan
Acceptance, Attitude, COVID-19, Saudi Arabia, Vaccination
Citation Information :
Alduwayghiri EM, Khan N. Acceptance and Attitude toward COVID-19 Vaccination among the Public in Saudi Arabia: A Cross-sectional Study. J Contemp Dent Pract 2021; 22 (7):730-734.
Aim and objective: This cross-sectional study aimed to investigate vaccine acceptance and attitude to novel coronavirus disease 2019 (COVID-19) vaccine among the general population in Saudi Arabia.
Materials and methods: The present study was conducted among the general population in Saudi Arabia above 18 years of age. The data were collected online, by questionnaire containing 20 questions using Google form, in both Arabic and English, and were distributed to friends, families, and relatives through mail, WhatsApp groups, and Twitter. The questionnaire was randomly given out to the people living in five provinces of Saudi Arabia.
Results: A sum of 1,713 participants responded to the online survey. The greatest number of participants were at the age between 31 years and 45 years (36.6%) and 56.4% were females. The results showed that 74.6% have not registered for the vaccination and 44.9% responded not to take the vaccine. About 60.80% were concerned about the side effects, and 48.2% were worried about the allergic reaction to COVID-19 vaccine. About 49.1% of participants agreed that preventive measures, such as wearing mask, social distance, and using sanitizers, keep the virus away, and 53.20% believes that being exposed to disease naturally is safer for the immune system. Around 23.90% believes that vaccination cannot reduce the possibility of getting COVID-19.
Conclusion: In the present study, the negative attitudes and afraid of the side effects of the vaccine are the most reasons for indecision and rejection about COVID-19 vaccine. For the future COVID-19 vaccination campaign not to fail, the Ministry of Saudi Arabia should closely follow the vaccination development processes, inform the public transparently, and consider public's concerns.
Clinical significance: The results of the current study will help the Ministry of Health in Saudi Arabia to attempt proactive missions by featuring the significance of immunization to the population and empowering vaccine take-up and acceptance.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
Al-Hanawi MK, Angawi K, Alshareef N, et al. Knowledge, attitude and practice toward COVID-19 among the public in the Kingdom of Saudi Arabia: a cross-sectional study. Front Public Health 2020;8:217. DOI: 10.3389/fpubh.2020.00217.
Bish A, Yardley L, Nicoll A, et al. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine 2011;29(38):6472–6484. DOI: 10.1016/j.vaccine.2011.06.107.
Wang Z, Schmidt F, Weisblum Y, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 2021:1–7. DOI: 10.1038/s41586-021-03324-6.
Kwok KO, Lai F, Wei WI, et al. Herd immunity–estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect 2020;80(6):e32–e33. DOI: 10.1016/j.jinf.2020.03.027.
Neumann-Böhme S, Varghese NE, Sabat I, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ 2020;21(7):977–982. DOI: 10.1007/s10198-020-01208-6.
Rhodes A, Hoq M, Measey MA, et al. Intention to vaccinate against COVID-19 in Australia. Lancet Infect Dis 2020;21(5):e110. DOI: 10.1016/S1473-3099(20)30724-6.
Nasser AA, Alzahrani RM, Fellah CA, et al. Measuring the patients’ satisfaction about telemedicine used in Saudi Arabia during COVID-19 pandemic. Cureus 2021;13(2):e13382. DOI: 10.7759/cureus.13382.
Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach to COVID-19 vaccine R&D. Science 2020;368(6494):948–950. DOI: 10.1126/science.abc5312.
El-Elimat T, Abu Al Samen MM, Almomani BA, et al. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS One 2021;16(4):e0250555. DOI: 10.1371/journal.pone.0250555.
Fu C, Wei Z, Pei S, et al. Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs). MedRxiv 2020. DOI: 10.1101/2020.04.09.20060103.
Thunstrom L, Ashworth M, Finnoff D, et al. Hesitancy towards a COVID-19 vaccine and prospects for herd immunity. Available at SSRN 3593098. 2020. DOI: 10.2139/ssrn.3593098.
Lazarus JV, Ratzan S, Palayew A, et al. Hesitant or not. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2020. DOI: 10.1038/s41591-020-1124-9.
Pogue K, Jensen JL, Stancil CK, et al. Influences on attitudes regarding potential COVID-19 vaccination in the United States. Vaccines 2020;8(4):582. DOI: 10.3390/vaccines8040582.
Wang K, Wong EL, Ho KF, et al. Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: a cross-sectional survey. Vaccine 2020;38(45):7049–7056. DOI: 10.1016/j.vaccine.2020.09.021.
Palamenghi L, Barello S, Boccia S, et al. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol 2020;35(8):785–788. DOI: 10.1007/s10654-020-00675-8.
Siegrist M, Zingg A. The role of public trust during pandemics: implications for crisis communication. Eur Psychol 2014;19(1):23. DOI: 10.1027/1016-9040/a000169.
Nitschke JP, Forbes PA, Ali N, et al. Resilience during uncertainty? Greater social connectedness during COVID-19 lockdown is associated with reduced distress and fatigue. Br J Health Psychol 2020;26(2):553–569. DOI: 10.1111/bjhp.12485.
Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an overview. Hum Vaccin Immunother 2013;9(8):1763–1773. DOI: 10.4161/hv.24657.
Spielmans GI, Parry PI. From evidence-based medicine to marketing-based medicine: evidence from internal industry documents. J Bioethical Inq 2010;7(1):13–29. DOI: 10.1007/s11673-010-9208-8.